References
Nguyen T, Toto RD (2008) Slowing chronic kidney disease progression: results of prospective clinical trials in adults. Pediatr Nephrol 23:1409–1422
MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD (2006) Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 48:8–20
Catapano F, Chiodini P, Nicola LD, Minutolo R, Zamboli P, Gallo C, Conte G (2008) Antiproteinuric response to dual blockade of the renin–angiotensin system in primary glomerulonephritis: meta-analysis and metaregression. Am J Kidney Dis doi:https://doi.org/10.1053/j.ajkd.2008.03.008
Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880–1888
Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Nogueira PC (2007) Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol 22:1309–1313
Zaffanello M, Franchini M, Fanos V (2008) New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy. Pharmacotherapy 28:125–130
Simonetti GD, von Vigier RO, Konrad M, Rizzi M, Fossali E, Bianchetti MG (2006) Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. Pediatr Nephrol 21:1480–1482
Litwin M, Grenda R, Sladowska J, Antoniewicz J (2006) Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 21:1716–1722
Wühl E, Schaefer F (2008) Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol 23:705–716
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zaffanello, M. Waiting for combined treatment with RAS inhibitors in children with primary glomerulonephritis. Pediatr Nephrol 24, 217–218 (2009). https://doi.org/10.1007/s00467-008-0936-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-008-0936-5